載藥微球肝動脈栓塞術,是使用載藥微球吸附化療藥物後,注射於肝動脈,結合化學治療與肝動脈栓塞術,簡化傳統肝癌之栓塞治療。藉由微球上化療藥物緩慢釋放,有效達到治療效果外,大幅降低化療藥物副作用,影響肝功能也較小。可延長病人存活時間,提高疾病控制率及較佳之生活品質。
Transhepatic arterial chemoembolization (TACE) with drug-eluting beads (DEBs) uses drugeluting microspheres to carry chemotherapy agents, and inject them into the hepatic artery. A combination of chemotherapy and transhepatic arterial chemoembolization can simplify traditional embolization therapy for hepatocellular carcinomas. The slow release of chemotherapy agents from the beads enhances treatment response, reduces the adverse effects of chemotherapy, and lowers the incidence of liver decompensation. Thus, TACE with DEBs prolongs patient survival, strengthens the disease remission rate, and provides a more favorable quality of life.